Biocon to transfer Biosimilars business to step down subsidiary

22 Aug 2017 Evaluate

Biocon has received an approval for transfer of Biosimilars business of the company by way of a slump sale as going concern to Biocon Biologics India, a step down subsidiary of the company, subject to consent of the shareholders of the company and obtaining all requisite regulatory / statutory approvals. The board of directors of the company at its meeting held on August 21, 2017 has approved for the same.

Biocon is India’s largest and Asia’s leading Biotechnology Company with a strategic focus on biopharmaceuticals and research services. It is a fully integrated, innovation-driven biopharma enterprise offering affordable solutions for chronic diseases to patient's worldwide.



Biocon Share Price

384.65 -5.90 (-1.51%)
16-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1782.80
Dr. Reddys Lab 1279.00
Cipla 1500.00
Zydus Lifesciences 913.90
Lupin 2089.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×